7MM Spinal Muscular Atrophy Opportunity Assessment and Forecasts 2023-2033 Featuring Eli Lilly and Co, Biogen, F. Hoffmann-La Roche,d Novartis, Scholar Rock, & Biohaven
29 juil. 2024 10h28 HE
|
Research and Markets
Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy: Opportunity Assessment and Forecast 2023-2033" report has been added to ResearchAndMarkets.com's offering. The diagnosed...